Summit Place Financial Advisors LLC Raises Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Summit Place Financial Advisors LLC boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,053 shares of the company’s stock after buying an additional 867 shares during the quarter. GE HealthCare Technologies makes up approximately 1.6% of Summit Place Financial Advisors LLC’s portfolio, making the stock its 29th biggest position. Summit Place Financial Advisors LLC’s holdings in GE HealthCare Technologies were worth $2,740,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. LGT Financial Advisors LLC lifted its position in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the last quarter. Capital Performance Advisors LLP bought a new stake in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Ashton Thomas Securities LLC bought a new stake in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Darwin Wealth Management LLC bought a new stake in GE HealthCare Technologies in the third quarter valued at approximately $31,000. Finally, Continuum Advisory LLC raised its holdings in shares of GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on GEHC. Wells Fargo & Company upped their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Citigroup upped their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Stock Up 0.5 %

GEHC stock opened at $92.67 on Wednesday. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The business’s 50-day moving average is $84.45 and its two-hundred day moving average is $85.67. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The company has a market cap of $42.38 billion, a price-to-earnings ratio of 21.40, a P/E/G ratio of 3.05 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. As a group, analysts forecast that GE HealthCare Technologies Inc. will post 4.66 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th were paid a $0.035 dividend. The ex-dividend date of this dividend was Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.15%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.